3,149.95
-20.05
(-0.63%)
At close: 2:12:12 PM CST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 12 | 12 | 19 | 18 |
Avg. Estimate | 21.67B | 22.5B | 90.23B | 93.78B |
Low Estimate | 21.37B | 22.32B | 89.37B | 91.46B |
High Estimate | 22.11B | 22.9B | 91.86B | 96.89B |
Year Ago Sales | 21.38B | 22.45B | 88.82B | 90.23B |
Sales Growth (year/est) | 1.33% | 0.22% | 1.59% | 3.93% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
JNJ.MX | -- | -- | -- | -- |
S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
Maintains | Barclays: Equal-Weight to Equal-Weight | 1/28/2025 |
Reiterates | RBC Capital: Outperform to Outperform | 1/23/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/23/2025 |
Maintains | Stifel: Hold to Hold | 1/23/2025 |
Maintains | Leerink Partners: Outperform to Outperform | 1/23/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/23/2025 |